Hangzhou China Resources Laotongjun Pharmaceutical Co., Ltd. · 66-41 · CHINA
For Hangzhou China Resources Laotongjun Pharmaceutical Co., Ltd., import alert is 66-41; country is CHINA; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; product is Kangbingdu (Antiviral Oral Solution) | Kangbingdu (Antiviral Oral Solution) | Kangbingdu (Antiviral Oral Solution) | Kangbingdu (Antiviral Oral Solution); product code is 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 58 E - - 99 Antiviral, NEC | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 06/04/2024; address is No. 88 Langyuan Road , Tonglu Economic Development Zone , Hangzhou, Cn-Zj CHINA, verified against its source on 2026-10-01.
- Firm
- Hangzhou China Resources Laotongjun Pharmaceutical Co., Ltd. verified
- Import alert
- 66-41
- Import alert name
- Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- Country
- CHINA verified
- Address
- No. 88 Langyuan Road , Tonglu Economic Development Zone , Hangzhou, Cn-Zj CHINA verified
- Date published
- 06/04/2024 verified
- Product code
- 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 58 E - - 99 Antiviral, NEC | 66 V - - 99 Miscellaneous Patent Medicines, Etc. each item verified
- Product
- Kangbingdu (Antiviral Oral Solution) | Kangbingdu (Antiviral Oral Solution) | Kangbingdu (Antiviral Oral Solution) | Kangbingdu (Antiviral Oral Solution) each item verified
- FDA notes
- The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its labeling includes claims such as: “Anti-viral oral solution” and “Is used for… cold, and influenza”. | The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its labeling includes claims such as: “Anti-viral oral solution” and “Is used for… cold, and influenza”. | The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its labeling includes claims such as: “Anti-viral oral solution” and “Is used for… cold, and influenza”. | The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its labeling includes claims such as: “Anti-viral oral solution” and “Is used for… cold, and influenza”. each item verified
What the source says
Hangzhou China Resources Laotongjun Pharmaceutical Co., Ltd. Date Published : 06/04/2024 No. 88 Langyuan Road , Tonglu Economic Development Zone , Hangzhou, Cn-Zj CHINA
— accessdata.fda.gov, retrieved 2026-09-15
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Product code, Product and FDA notes
54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. Date Published: 06/04/2024 Desc: Kangbingdu (Antiviral Oral Solution) Notes: The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its labeling includes claims such as: “Anti-viral oral solution” and “Is used for… cold, and influenza”. 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. Date Published: 06/04/2024 Desc: Kangbingdu (Antiviral Oral Solution) Notes: The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its labeling includes claims such as: “Anti-viral oral solution” and “Is used for… cold, and influenza”. 58 E - - 99 Antiviral, NEC Date Published: 06/04/2024 Desc: Kangbingdu (Antiviral Oral Solution) Notes: The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its labeling includes claims such as: “Anti-viral oral solution” and “Is used for… cold, and influenza”. 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 06/04/2024 Desc: Kangbingdu (Antiviral Oral Solution) Notes: The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its labeling includes claims such as: “Anti-viral oral solution” and “Is used for… cold, and influenza”.
— all from accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_190.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.